Medtronic Pre-Tax Profit Margin 2010-2025 | MDT
Current and historical pre-tax profit margin for Medtronic (MDT) from 2010 to 2025. Pre-tax profit margin can be defined as earnings before taxes as a portion of total revenue. Medtronic pre-tax profit margin for the three months ending April 30, 2025 was .
| Medtronic Pre-Tax Profit Margin Historical Data | |||
|---|---|---|---|
| Date | TTM Revenue | TTM Pre-Tax Income | Pre-Tax Margin |
| 2025-04-30 | $33.54B | $5.63B | 16.78% |
| 2025-01-31 | $33.20B | $5.22B | 15.73% |
| 2024-10-31 | $33.00B | $5.16B | 15.62% |
| 2024-07-31 | $32.58B | $4.91B | 15.07% |
| 2024-04-30 | $32.36B | $4.84B | 14.95% |
| 2024-01-31 | $32.32B | $5.53B | 17.11% |
| 2023-10-31 | $31.96B | $5.43B | 17.00% |
| 2023-07-31 | $31.56B | $5.52B | 17.48% |
| 2023-04-30 | $31.23B | $5.36B | 17.18% |
| 2023-01-31 | $30.77B | $5.42B | 17.60% |
| 2022-10-31 | $30.81B | $5.63B | 18.27% |
| 2022-07-31 | $31.07B | $5.73B | 18.44% |
| 2022-04-30 | $31.69B | $5.52B | 17.41% |
| 2022-01-31 | $31.79B | $5.48B | 17.24% |
| 2021-10-31 | $31.80B | $5.11B | 16.08% |
| 2021-07-31 | $31.60B | $4.14B | 13.12% |
| 2021-04-30 | $30.12B | $3.90B | 12.93% |
| 2021-01-31 | $27.93B | $2.53B | 9.07% |
| 2020-10-31 | $27.87B | $2.89B | 10.38% |
| 2020-07-31 | $27.93B | $3.66B | 13.11% |
| 2020-04-30 | $28.91B | $4.06B | 14.02% |
| 2020-01-31 | $31.06B | $5.14B | 16.55% |
| 2019-10-31 | $30.89B | $4.93B | 15.97% |
| 2019-07-31 | $30.67B | $4.99B | 16.29% |
| 2019-04-30 | $30.56B | $5.20B | 17.01% |
| 2019-01-31 | $30.56B | $5.63B | 18.43% |
| 2018-10-31 | $30.38B | $5.29B | 17.40% |
| 2018-07-31 | $29.95B | $5.66B | 18.90% |
| 2018-04-30 | $29.95B | $5.68B | 18.95% |
| 2018-01-31 | $29.73B | $5.39B | 18.12% |
| 2017-10-31 | $29.64B | $5.33B | 17.97% |
| 2017-07-31 | $29.93B | $4.81B | 16.07% |
| 2017-04-30 | $29.71B | $4.60B | 15.49% |
| 2017-01-31 | $29.36B | $4.30B | 14.65% |
| 2016-10-31 | $29.01B | $4.51B | 15.56% |
| 2016-07-31 | $28.73B | $4.38B | 15.26% |
| 2016-04-30 | $28.83B | $4.34B | 15.04% |
| 2016-01-31 | $28.57B | $3.39B | 11.86% |
| 2015-10-31 | $25.95B | $3.40B | 13.12% |
| 2015-07-31 | $23.26B | $3.34B | 14.37% |
| 2015-04-30 | $20.26B | $3.49B | 17.21% |
| 2015-01-31 | $17.52B | $3.78B | 21.57% |
| 2014-10-31 | $17.37B | $3.54B | 20.39% |
| 2014-07-31 | $17.20B | $3.64B | 21.14% |
| 2014-04-30 | $17.01B | $3.71B | 21.79% |
| 2014-01-31 | $16.90B | $4.38B | 25.91% |
| 2013-10-31 | $16.76B | $4.58B | 27.31% |
| 2013-07-31 | $16.67B | $4.32B | 25.90% |
| 2013-04-30 | $16.59B | $4.25B | 25.62% |
| 2013-01-31 | $16.43B | $4.13B | 25.13% |
| 2012-10-31 | $16.32B | $4.03B | 24.67% |
| 2012-07-31 | $16.25B | $4.22B | 25.94% |
| 2012-04-30 | $16.18B | $4.15B | 25.61% |
| 2012-01-31 | $15.86B | $3.99B | 25.15% |
| 2011-10-31 | $15.80B | $3.93B | 24.89% |
| 2011-07-31 | $15.68B | $3.64B | 23.23% |
| 2011-04-30 | $15.51B | $3.66B | 23.63% |
| 2011-01-31 | $15.30B | $4.00B | 26.13% |
| 2010-10-31 | $15.30B | $4.07B | 26.57% |
| 2010-07-31 | $15.23B | $4.42B | 29.04% |
| 2010-04-30 | $15.39B | $3.94B | 25.62% |
| 2010-01-31 | $15.45B | $2.74B | 17.75% |
| 2009-10-31 | $15.09B | $2.57B | 17.05% |
| Sector | Industry | Market Cap | Revenue |
|---|---|---|---|
| Medical | Medical Products Manufacturing | $114.826B | $33.537B |
| Medtronic, Inc. acquired Ireland-based Covidien plc. The acquisition resulted in the formation of a new holding company incorporated in Ireland - Medtronic plc. The company currently generates revenues from four major segments - namely Cardiovascular Portfolio, Medical Surgical Portfolio, Neuroscience Portfolio and Diabetes. The Cardiovascular Portfolio, formerly reported as the Cardiac and Vascular Group, includes the Cardiac Rhythm & Heart Failure, Structural Heart & Aortic and Coronary & Peripheral Vascular divisions. The Medical Surgical Portfolio, formerly reported as the Minimally Invasive Therapies Group, includes the Surgical Innovations and the Respiratory, Gastrointestinal & Renal divisions. Neuroscience consists of Cranial & Spinal Technologies, Specialty The Neuroscience Portfolio, formerly reported as the Restorative Therapies Group, includes the Cranial & Spinal Technologies, Specialty Therapies, and Neuromodulation divisions. | |||
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Abbott Laboratories (ABT) | United States | $209.668B | 24.59 |
| Boston Scientific (BSX) | United States | $154.824B | 38.76 |
| Stryker (SYK) | United States | $148.439B | 31.04 |
| EssilorLuxottica (ESLOY) | France | $131.494B | 0.00 |
| Lonza Group Ag (LZAGY) | Switzerland | $49.743B | 0.00 |
| Haleon (HLN) | United Kingdom | $43.081B | 24.59 |
| ResMed (RMD) | United States | $37.598B | 28.24 |
| GE HealthCare Technologies (GEHC) | United States | $34.909B | 16.57 |
| Agilent Technologies (A) | United States | $33.054B | 21.55 |
| Terumo (TRUMY) | Japan | $24.345B | 31.62 |
| Koninklijke Philips (PHG) | Netherlands | $23.697B | 16.63 |
| Insulet (PODD) | United States | $19.948B | 78.30 |
| Zimmer Biomet Holdings (ZBH) | United States | $18.776B | 12.06 |
| Baxter (BAX) | United States | $14.312B | 10.69 |
| Smith & Nephew SNATS (SNN) | United Kingdom | $13.087B | 0.00 |
| Sunny Optical Technology (SNPTF) | China | $10.417B | 0.00 |
| Demant (WILYY) | Denmark | $8.633B | 0.00 |
| Bio-Rad Laboratories (BIO) | United States | $6.794B | 23.64 |
| Lantheus Holdings (LNTH) | United States | $5.092B | 12.85 |
| Perrigo (PRGO) | Ireland | $3.733B | 9.46 |
| Prestige Consumer Healthcare (PBH) | United States | $3.713B | 16.58 |
| Haemonetics (HAE) | United States | $3.529B | 16.07 |
| Shandong Weigao Medical Polymer (SHWGF) | China | $3.459B | 0.00 |
| Envista Holdings (NVST) | United States | $3.347B | 27.82 |
| ICU Medical (ICUI) | United States | $3.070B | 22.64 |
| LeMaitre Vascular (LMAT) | United States | $1.855B | 41.47 |
| QuidelOrtho (QDEL) | United States | $1.804B | 12.41 |
| AtriCure (ATRC) | United States | $1.473B | 0.00 |
| Acuren (TIC) | United States | $1.444B | 0.00 |
| AdaptHealth (AHCO) | United States | $1.242B | 12.60 |
| Green Thumb Industries (GTBIF) | United States | $1.207B | 27.14 |
| Phibro Animal Health (PAHC) | United States | $1.205B | 15.40 |
| Neogen (NEOG) | United States | $1.055B | 13.50 |
| BioLife Solutions (BLFS) | United States | $1.025B | 0.00 |
| InMode (INMD) | Israel | $0.891B | 8.98 |
| Kestra Medical Technologies (KMTS) | United States | $0.845B | 0.00 |
| Curaleaf Holdings (CURLF) | Canada | $0.674B | 0.00 |
| Maravai LifeSciences Holdings (MRVI) | United States | $0.639B | 0.00 |
| Owens & Minor (OMI) | United States | $0.617B | 5.12 |
| Tilray Brands (TLRY) | Canada | $0.615B | 0.00 |
| Evolus (EOLS) | United States | $0.602B | 0.00 |
| CeriBell (CBLL) | United States | $0.565B | 0.00 |
| Valneva SE (VALN) | France | $0.553B | 0.00 |
| Surmodics (SRDX) | United States | $0.438B | 0.00 |
| SNDL (SNDL) | Canada | $0.410B | 0.00 |
| Capricor Therapeutics (CAPR) | United States | $0.327B | 0.00 |
| VAREX IMAGING (VREX) | United States | $0.323B | 11.89 |
| Sanuwave Health (SNWV) | United States | $0.321B | 0.00 |
| SEMPERIT AG HLD (SEIGY) | Austria | $0.304B | 0.00 |
| Quanterix (QTRX) | United States | $0.275B | 0.00 |
| Cresco Labs (CRLBF) | United States | $0.270B | 0.00 |
| Viemed Healthcare (VMD) | United States | $0.264B | 22.23 |
| Cerus (CERS) | United States | $0.262B | 0.00 |
| Aurora Cannabis (ACB) | Canada | $0.256B | 75.83 |
| OraSure Technologies (OSUR) | United States | $0.245B | 0.00 |
| Sanara MedTech (SMTI) | United States | $0.244B | 0.00 |
| ZimVie (ZIMV) | United States | $0.241B | 10.96 |
| Biote (BTMD) | United States | $0.228B | 6.42 |
| Brainsway (BWAY) | Israel | $0.219B | 58.05 |
| Verano Holdings (VRNOF) | United States | $0.204B | 0.00 |
| Canopy Growth (CGC) | Canada | $0.204B | 0.00 |
| Omeros (OMER) | United States | $0.204B | 0.00 |
| High Tide (HITI) | Canada | $0.203B | 0.00 |
| Organigram Global (OGI) | Canada | $0.196B | 0.00 |
| Utah Medical Products (UTMD) | United States | $0.182B | 14.82 |
| TriSalus Life Sciences (TLSI) | United States | $0.179B | 0.00 |
| Exagen (XGN) | United States | $0.153B | 0.00 |
| Vireo Growth (VREOF) | United States | $0.150B | 0.00 |
| FitLife Brands (FTLF) | United States | $0.125B | 15.33 |
| TerrAscend (TSNDF) | Canada | $0.107B | 0.00 |
| Jin Medical (ZJYL) | China | $0.101B | 0.00 |
| Fonar (FONR) | United States | $0.099B | 12.74 |
| MacroGenics (MGNX) | United States | $0.097B | 0.00 |
| Veru (VERU) | United States | $0.090B | 0.00 |
| Quipt Home Medical (QIPT) | United States | $0.090B | 0.00 |
| Oramed Pharmaceuticals (ORMP) | United States | $0.087B | 0.00 |
| Apyx Medical (APYX) | United States | $0.086B | 0.00 |
| Jushi Holdings (JUSHF) | United States | $0.081B | 0.00 |
| Zynex (ZYXI) | United States | $0.071B | 0.00 |
| Agape ATP (ATPC) | $0.071B | 0.00 | |
| InterCure (INCR) | Israel | $0.068B | 0.00 |
| Cytosorbents (CTSO) | United States | $0.062B | 0.00 |
| ImmuCell (ICCC) | United States | $0.060B | 0.00 |
| Safety Shot (SHOT) | United States | $0.052B | 0.00 |
| United-Guardian (UG) | United States | $0.042B | 14.54 |
| Nephros (NEPH) | United States | $0.038B | 51.14 |
| Modular Medical (MODD) | United States | $0.038B | 0.00 |
| Rockwell Medical (RMTI) | United States | $0.037B | 0.00 |
| Allurion Technologies (ALUR) | United States | $0.022B | 0.00 |
| INLIF (INLF) | $0.016B | 0.00 | |
| Flora Growth (FLGC) | United States | $0.014B | 0.00 |
| Meihua Medical Technologies (MHUA) | China | $0.014B | 0.00 |
| IM Cannabis (IMCC) | Canada | $0.014B | 0.00 |
| Trinity Biotech (TRIB) | Ireland | $0.013B | 0.00 |
| Senestech (SNES) | United States | $0.011B | 0.00 |
| Cellectar Biosciences (CLRB) | United States | $0.009B | 0.00 |
| Innovative Eyewear (LUCY) | United States | $0.007B | 0.00 |
| Sharps Technology (STSS) | United States | $0.006B | 0.00 |
| GlucoTrack (GCTK) | United States | $0.003B | 0.00 |
| Akanda (AKAN) | Canada | $0.002B | 0.00 |
| InVivo Therapeutics Holdings (NVIVQ) | United States | $0.000B | 0.00 |